|
PIAS4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64209978947838E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72589720293104E-11 |
| Normal-vs-Stage2 |
8.51180000038809E-07 |
| Normal-vs-Stage3 |
1.693800E-01 |
| Normal-vs-Stage4 |
4.278100E-02 |
| Stage1-vs-Stage2 |
5.508200E-01 |
| Stage1-vs-Stage3 |
5.959500E-03 |
| Stage1-vs-Stage4 |
9.708000E-01 |
| Stage2-vs-Stage3 |
6.502100E-03 |
| Stage2-vs-Stage4 |
7.641400E-01 |
| Stage3-vs-Stage4 |
1.460970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.46579448368334E-11 |
| Normal-vs-AfricanAmerican |
1.73612999999628E-05 |
| Normal-vs-Asian |
2.993000E-01 |
| Caucasian-vs-AfricanAmerican |
6.271400E-01 |
| Caucasian-vs-Asian |
4.027600E-01 |
| AfricanAmerican-vs-Asian |
5.471400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.91269222682422E-12 |
| Normal-vs-Female |
6.782900E-03 |
| Male-vs-Female |
6.606800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.08200000000525E-05 |
| Normal-vs-Extreme_Weight |
7.33857419277228E-14 |
| Normal-vs-Obese |
2.766500E-04 |
| Normal-vs-Extreme_Obese |
1.929390E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.835390E-01 |
| Normal_Weight-vs-Obese |
3.475400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.743800E-01 |
| Extreme_Weight-vs-Obese |
6.623700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.017400E-01 |
| Obese-vs-Extreme_Obese |
8.414000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.687400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.00910000000454E-06 |
| Normal-vs-Age(61-80Yrs) |
6.60094201521133E-12 |
| Normal-vs-Age(81-100Yrs) |
2.03079999999689E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.373600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.241600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.200600E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.596200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.456000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.755600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.25249810523087E-11 |
| Normal-VS-Type2 PRCC |
2.75640000002575E-06 |
| Normal-VS-KIRP CIMP |
2.939400E-01 |
| Normal-VS-Unclassified PRCC |
2.239500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.025600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.011570E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.405600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.758000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.993800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.753600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.23210000002594E-06 |
| Normal-vs-N1 |
3.884200E-01 |
| Normal-vs-N2 |
2.699600E-03 |
| N0-vs-N1 |
3.559900E-02 |
| N0-vs-N2 |
9.388800E-01 |
| N1-vs-N2 |
3.659200E-01 |
|
|
